Found: 20
Select item for more details and to access through your institution.
A phase I/II study of preoperative letrozole, everolimus, and carotuximab in stage 2 and 3 hormone receptor-positive and Her2-negative breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2023, v. 198, n. 2, p. 217, doi. 10.1007/s10549-023-06864-9
- By:
- Publication type:
- Article
Estrogen therapy after breast cancer diagnosis and breast cancer mortality risk.
- Published in:
- Breast Cancer Research & Treatment, 2023, v. 198, n. 2, p. 361, doi. 10.1007/s10549-023-06871-w
- By:
- Publication type:
- Article
Chemotherapy refusal and subsequent survival in healthy older women with high genomic risk estrogen receptor-positive breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2023, v. 198, n. 2, p. 309, doi. 10.1007/s10549-023-06862-x
- By:
- Publication type:
- Article
High maximum standardized uptake value might be associated more with T2b (≥ 4 cm) than T2a (< 4 cm) in patients with T2N1 hormone receptor-positive, ERBB2-negative breast cancer.
- Published in:
- 2023
- By:
- Publication type:
- Letter
Contrast-enhanced mammography in the assessment of residual disease after neoadjuvant treatment.
- Published in:
- Breast Cancer Research & Treatment, 2023, v. 198, n. 2, p. 349, doi. 10.1007/s10549-023-06865-8
- By:
- Publication type:
- Article
Neighborhood and racial influences on triple negative breast cancer: evidence from Northeast Ohio.
- Published in:
- Breast Cancer Research & Treatment, 2023, v. 198, n. 2, p. 369, doi. 10.1007/s10549-023-06883-6
- By:
- Publication type:
- Article
Comparison of goserelin and leuprorelin for ovarian protection during chemotherapy in young patients with breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2023, v. 198, n. 2, p. 231, doi. 10.1007/s10549-023-06877-4
- By:
- Publication type:
- Article
False-positive incidental lesions detected on contrast-enhanced breast MRI: clinical and imaging features.
- Published in:
- Breast Cancer Research & Treatment, 2023, v. 198, n. 2, p. 321, doi. 10.1007/s10549-023-06861-y
- By:
- Publication type:
- Article
Prognostic significance of pretreatment <sup>18</sup>F-fluorodeoxyglucose positron emission tomography/computed tomography in patients with T2N1 hormone receptor-positive, ERBB2-negative breast cancer who underwent adjuvant chemotherapy.
- Published in:
- Breast Cancer Research & Treatment, 2023, v. 198, n. 2, p. 207, doi. 10.1007/s10549-022-06852-5
- By:
- Publication type:
- Article
Distinct breast cancer phenotypes in BRCA 1/2 carriers based on ER status.
- Published in:
- Breast Cancer Research & Treatment, 2023, v. 198, n. 2, p. 197, doi. 10.1007/s10549-022-06851-6
- By:
- Publication type:
- Article
International development of a patient-centered core outcome set for assessing health-related quality of life in metastatic breast cancer patients.
- Published in:
- Breast Cancer Research & Treatment, 2023, v. 198, n. 2, p. 265, doi. 10.1007/s10549-022-06827-6
- By:
- Publication type:
- Article
Comparison between de novo and metachronous metastatic breast cancer: the presence of a primary tumour is not the only difference—a Dutch population-based study from 2008 to 2018.
- Published in:
- Breast Cancer Research & Treatment, 2023, v. 198, n. 2, p. 253, doi. 10.1007/s10549-022-06837-4
- By:
- Publication type:
- Article
Validation of a breast cancer risk prediction model based on the key risk factors: family history, mammographic density and polygenic risk.
- Published in:
- Breast Cancer Research & Treatment, 2023, v. 198, n. 2, p. 335, doi. 10.1007/s10549-022-06834-7
- By:
- Publication type:
- Article
Pregnancy-associated breast cancer: does timing of presentation affect outcome?
- Published in:
- Breast Cancer Research & Treatment, 2023, v. 198, n. 2, p. 283, doi. 10.1007/s10549-022-06833-8
- By:
- Publication type:
- Article
Outcomes for the first four lines of therapy in patients with HER2-positive advanced breast cancer: results from the SONABRE registry.
- Published in:
- Breast Cancer Research & Treatment, 2023, v. 198, n. 2, p. 239, doi. 10.1007/s10549-022-06832-9
- By:
- Publication type:
- Article
Immediate or delayed oncoplastic surgery after breast conserving surgery at the Netherlands Cancer Institute: a cohort study of 251 cases.
- Published in:
- Breast Cancer Research & Treatment, 2023, v. 198, n. 2, p. 295, doi. 10.1007/s10549-022-06841-8
- By:
- Publication type:
- Article
Use of endocrine therapy for estrogen receptor-positive breast cancer among American Indians and Alaska natives.
- Published in:
- Breast Cancer Research & Treatment, 2023, v. 198, n. 2, p. 187, doi. 10.1007/s10549-022-06826-7
- By:
- Publication type:
- Article
Outcomes and clinicopathologic characteristics associated with disseminated tumor cells in bone marrow after neoadjuvant chemotherapy in high-risk early stage breast cancer: the I-SPY SURMOUNT study.
- Published in:
- Breast Cancer Research & Treatment, 2023, v. 198, n. 2, p. 383, doi. 10.1007/s10549-022-06803-0
- By:
- Publication type:
- Article
Molecular characteristics of Asian male BRCA-related cancers.
- Published in:
- 2023
- By:
- Publication type:
- Letter
Mitigating fear of cancer recurrence.
- Published in:
- 2023
- By:
- Publication type:
- Letter